批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期 | 提交号 | 审批结论 | 申请内容分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
2017/06/22 |
SUPPL-23(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2016/07/27 |
SUPPL-22(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2015/04/16 |
SUPPL-21(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2008/07/28 |
SUPPL-17(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2003/06/11 |
SUPPL-15(补充) |
Approval |
Labeling |
STANDARD
|
|
|
1993/10/27 |
SUPPL-14(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1993/09/23 |
SUPPL-13(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1990/05/29 |
SUPPL-11(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1986/11/10 |
SUPPL-7(补充) |
Approval |
Labeling |
|
|
|
1985/10/28 |
SUPPL-10(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1985/09/10 |
SUPPL-9(补充) |
Approval |
Labeling |
|
|
|
1984/10/30 |
SUPPL-8(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1981/05/15 |
SUPPL-6(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1977/02/07 |
SUPPL-5(补充) |
Approval |
Labeling |
|
|
|
1976/09/11 |
SUPPL-4(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1952/01/23 |
ORIG-1(原始申请) |
Approval |
Type 5 - New Formulation or New Manufacturer |
STANDARD
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号 | 专利号 | 专利过期日 | 是否物质专利 | 是否产品专利 | 专利用途代码 | 撤销请求 | 提交日期 | 专利下载 | 备注 |
无 |
与本品治疗等效的药品
活性成分:PRIMAQUINE PHOSPHATE 剂型/给药途径:TABLET;ORAL 规格:EQ 15MG BASE 治疗等效代码:AB
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
008316 |
001 |
NDA |
PRIMAQUINE |
PRIMAQUINE PHOSPHATE |
TABLET;ORAL |
EQ 15MG BASE |
Prescription |
Yes |
Yes |
AB |
Approved Prior to Jan 1, 1982
|
SANOFI AVENTIS US |
204476 |
001 |
ANDA |
PRIMAQUINE PHOSPHATE |
PRIMAQUINE PHOSPHATE |
TABLET;ORAL |
EQ 15MG BASE |
Prescription |
No |
No |
AB |
2014/02/25
|
UNICHEM |
206043 |
001 |
ANDA |
PRIMAQUINE PHOSPHATE |
PRIMAQUINE PHOSPHATE |
TABLET;ORAL |
EQ 15MG BASE |
Prescription |
No |
No |
AB |
2016/06/23
|
NOVAST LABS |